Navigation Links
Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
Date:3/13/2013

25,1147,706Deferred revenue, less current portion 

38,57142,000Other long-term liabilities 

-288Commitments and contingenciesStockholders' equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at December 31, 2012 and 2011; noshares issued and outstanding atDecember 31, 2012 and 2011--Common stock, $.001 par value, 300,000,000shares authorized at December 31, 2012 and2011;84,413,670 and 61,285,514 shares issued and outstanding at December 31, 2012 and 2011, respectively

8461Additional paid-in capital 

512,174446,357Accumulated other comprehensive income (loss)

15(2)Accumulated deficit

(436,804)(346,710)Total stockholders' equity 

75,46999,706Total liabilities and stockholders' equity 

$
39,154$
49,700 

Orexigen Therapeutics, Inc.Statements of Operations(In thousands, except per share amounts)(Unaudited)Three Months Ended Twelve Months Ended December 31, December 31, 2012201120122011Revenues:Collaborative agreement $

857$

857$

3,428$

3,428License revenue 000971Total revenues 8578573,4284,399Operating expenses:Research and development 28,2521,54373,68012,780General and administrative 5,0823,63219,98719,502Total operating expenses 33,3345,17593,66732,282Loss from operations (32,477)(4,318)(90,239)(27,883)Other income (expense):Interest income 221114746Interest expense --(2)(221)Total other income (expense) 2211145(175)Net loss $

(32,455)$

(4,307)$

(90,094)$

(28,058)Net loss per share - basic and diluted $

(0.41)$

(0.09)$

(1.27)$

(0.58)Shares used in computing net loss per share – basic and diluted 78,95249,04870,73948,273


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
10. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
11. Orexigen Therapeutics to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015  Mylan ... its shareholders have approved Mylan,s proposed acquisition of ... and the related issuance of Mylan ordinary shares ... of shareholders held today. The transaction received the ... general meeting. In addition, the transaction received support ...
(Date:8/28/2015)... Massachusetts y LONDRES, 28 de agosto ... AEX: PHIA) anunció hoy su participación en el  ... exhibirá sus soluciones cardiológicas más recientes y novedosas, ... Cardiovascular, que conectan a las personas y la ... de ayudar a diagnosticar, guiar los tratamientos y ...
(Date:8/27/2015)... Aug. 27, 2015  The Academy of Managed ... Drug Administration,s (FDA,s) draft guidance and proposed rule ... biosimilars, to bear a nonproprietary name with an ... seeking a decision from the FDA on the ... care stakeholders urging the agency to use the ...
Breaking Medicine Technology:Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... Osteotech, Inc. (Nasdaq: OSTE ), a ... regenerative healing, announced today that its patent supporting the ... the Research and Development Council of New Jersey,s 31st ...  Osteotech was chosen from a broad field of nominees ...
... Dendreon Corporation (Nasdaq: DNDN ) today reported ... the third quarter ended September 30, 2010 was $20.2 million ... Revenue for the nine months ended September 30, 2010 was ... September 30, 2009.   Revenue from sales of ...
Cached Medicine Technology:Osteotech's Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council 2Osteotech's Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council 3Dendreon Reports Third Quarter 2010 Financial Results 2Dendreon Reports Third Quarter 2010 Financial Results 3Dendreon Reports Third Quarter 2010 Financial Results 4
(Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... Avid collector ... and the Doors Shrine Auditorium concert posters. This hand colored artwork is one of ... 23 in Los Angles. Hawley states, "When the doors played the Shrine, the ...
(Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... ... Magazine: The Fun Cooking Magazine for Kids , recently elected two new officers ... These appointments will further ChopChop’s mission of inspiring and teaching kids to cook ...
(Date:8/30/2015)... , ... August 30, 2015 , ... Scientists in France ... also a range of digestive cancers. Surviving Mesothelioma has just posted an article on ... the University of Caen measured the cancer incidence among 2,024 French asbestos plant workers ...
(Date:8/30/2015)... Raton, Fl (PRWEB) , ... August 30, 2015 ... ... that Kathleen Kall has been promoted from Administrative assistant to Executive Assistant to ... you’ll interact with a proven professional, focused on your goals. Kathleen graduated ...
(Date:8/29/2015)... , ... August 29, 2015 , ... On Saturday, September ... Mesothelioma Applied Research Foundation (Meso Foundation) will present an educational program titled “Asbestos ... PM and lasts through 9:30 PM (doors open at 6:45pm) at Calvary United Methodist ...
Breaking Medicine News(10 mins):Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2
... following Webcast:, What: HCA Healthcare Webcast, ... Where: http://www.videonewswire.com/event.asp?id=55052 , How: ... address above., ... +1-615 344 2688, , ...
... Power, a business of Emerson and the global leader in ... series wall mount switching adapters, designed specifically for medical and ... ... Carlsbad, CA (PRWEB) January 27, 2009 -- Emerson Network ...
... MENTOR, Ohio, Jan. 27 STERIS Corporation (NYSE:, ... 2009 third quarter ended,December 31, 2008. Fiscal 2009 ... $314.0 million in the third quarter of fiscal 2008,driven ... Fiscal 2009 third,quarter net income was $28.6 million, or ...
... Tenn., Jan. 27 LTC Consultants announced today,that its ... on,May 20-21, 2009 in Nashville, TN. , ... event of 2009 because it is,100% sales training from ... to Bill Pomakoy, LTC Consultants, VP of Marketing. ...
... WALTHAM, Mass., Jan. 27 Interleukin Genetics, Inc. (NYSE Alternext US: ... to the NYSE Alternext US LLC (the "Exchange") that outlines ... listing requirements. The Company expects the Exchange to formally ... plan is accepted, the Company may be able to continue ...
... Texas at San Antonio (UTSA) has received another boost ... been awarded a $199,884, 24-month grant by the U.S. ... is one of the first grants we have received ... efficiency," said Efstathios Michaelides, mechanical engineering professor, department chair ...
Cached Medicine News:Health News:Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications 2Health News:Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications 3Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 10Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 11Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 12Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 13Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 14Health News:Phyllis Shelton's LTCI Sales Skills Seminar a Must-Attend Event for Insurance Professionals 2Health News:Interleukin Genetics' Submits Plan to Regain Compliance with Continued Listing Standards 2Health News:UTSA receives federal funding for fossil fuel research 2
1000 L, Bulk, blue Recommended for 500 and 1000 L pipettes....
... to order tips. Each box contains 1000 tips ... contains 200 tips (4 bags of 50 tips). ... 200 tips per pack. Bulk Packs are sealed ... opened for quick access to Gilsons Diamond Tips. ...
This 100 µL is the equivalent to the "Universal Blue" tips and fits virtually every manufacturer's 1000 µL Pipettor....
300 L, Bulk Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette...
Medicine Products: